A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Trandolapril Tablets (Trandolapril)

Angiotensin Converting Enzyme Inhibitor class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2015-03-31
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Trandolapril Tablets used for?

Trandolapril Tablets is a Angiotensin Converting Enzyme Inhibitor medication tracked in Medicare Part D.

Is there a generic for Trandolapril Tablets?

No. Trandolapril Tablets is brand-only with no generic equivalents currently in market.

How much does my plan pay for Trandolapril Tablets?

NADAC pricing data not currently available for this drug.

Is Trandolapril Tablets on the FDA shortage list?

No. Trandolapril Tablets is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Angiotensin Converting Enzyme Inhibitor4 alternatives in D1
01
Captopril
Angiotensin Converting Enzyme Inhibitor
$0.138Lowest NADAC
7Generic mfrs
$7.1MCY24 Part D spend
Compare →
02
Ramipril
Brand: Vostally
$0.053Lowest NADAC
8Generic mfrs
$27.4MCY24 Part D spend
Compare →
03
Trandolapril
Angiotensin Converting Enzyme Inhibitor
$0.190Lowest NADAC
3Generic mfrs
$2.0MCY24 Part D spend
Compare →
04
Trandolapril and Verapamil
Angiotensin Converting Enzyme Inhibitor
Lowest NADAC
1Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.